Genfit S.A. (EPA:GNFT)
France
· Delayed Price · Currency is EUR 8.90
+0.38 (4.40%)
Mar 9, 2026, 5:35 PM CET
Genfit Employees
Genfit had 188 employees as of June 30, 2025. The number of employees increased by 8 or 4.44% since the number was reported on December 31, 2024.
Employees
188
Change
8
Growth
4.44%
Revenue / Employee
€240,027
Profits / Employee
€206,170
Market Cap
424.26M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MedinCell | 145 |
| Cellectis | 222 |
| Valneva SE | 700 |
| Transgene | 147 |
| Inventiva | 84 |
| DBV Technologies | 117 |
| Innate Pharma | 174 |
| Nanobiotix | 103 |
Genfit News
- 25 days ago - GENFIT to receive US$20M milestone after Ipsen's Iqirvo® exceeds the US$200M threshold in its first full year of net sales - GlobeNewsWire
- 2 months ago - GENFIT Announces 2026 Financial Calendar - GlobeNewsWire
- 3 months ago - GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy - GlobeNewsWire
- 3 months ago - GENFIT Announces Appointment of new Chief Medical Officer - GlobeNewsWire
- 3 months ago - GENFIT Reports Third Quarter 2025 Financial Information and Provides a Corporate Update - GlobeNewsWire
- 3 months ago - GENFIT announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market - GlobeNewsWire
- 4 months ago - GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF - GlobeNewsWire
- 4 months ago - GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting® 2025 - GlobeNewsWire